Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment
Hiroyasu Kaneda,1 Takeshi Yoshida,1 Isamu Okamoto2 1Department of Medical Oncology, Kinki University, Osakasayama, Japan; 2Center for Clinical and Translational Research, Kyushu Eyeshadow Brushes University Hospital, Fukuoka, Japan Abstract: The discovery of activating mutations in the epidermal growth-factor receptor (EGFR) gene in 2004 opened a n